Literature DB >> 30606807

Venetoclax in AML: aiming for "just right".

Laura C Michaelis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30606807     DOI： 10.1182/blood-2018-11-883454

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.

Authors:  Evan M Cherry; Diana Abbott; Maria Amaya; Christine McMahon; Marc Schwartz; Julie Rosser; Audrey Sato; Jeffrey Schowinsky; Anagha Inguva; Mohd Minhajuddin; Shanshan Pei; Brett Stevens; Amanda Winters; Craig T Jordan; Clayton Smith; Jonathan A Gutman; Daniel A Pollyea
Journal:  Blood Adv       Date:  2021-12-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.